Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials

Table 3 Baseline features of the studies

Studies	Age (years)	Males (%)	HBP (%)	Smoker (%)	DL (%)	Previous MI (%)	HbA1c (%)	Previous stroke (%)	BMI kg/m²
	DM/NDM	DM/NDM	DM/NDM	DM/NDM	DM/NDM	DM/NDM	DM/NDM	DM/NDM	DM/NDM
Global Leaders [13]	68.2/67.3	69.3/71.1	88.7/75.7	17.3/22.7	75.8/65.2	28.8/23.6	-	4.55/2.80	29.8/27.8
Twilight DM CKD [15]	65.8/67.4	73.1/73.3	85.0/72.3	15.7/20.3	71.7/60.3	30.1/27.4	-	-	30.1/27.8
Tico [16]	63.3/60.0	73.3/81.8	68.3/43.7	31.9/39.4	64.1/59.0	64.0/71.9	7.70/5.90	7.40/2.90	25.1/24.9

Abbreviation: DM Diabetes mellitus, NDM Non-diabetes mellitus, HBP High blood pressure, DL Dyslipidemia, CKD Chronic kidney disease, MI Myocardial infarction, HbA1c glycated hemoglobin, BMI Body mass index

ISSN: 1471-2261